E-mail us:
service@prospectnews.com
Or call: 212 374 2800
Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
Add to balance / Manage account
Not logged in
Prospect News home
>
Main news index
>
All issuers starting with I
>
Issuers starting with I, PP only
>
All stories on Interleukin Genetics Inc.
>
Stories on Interleukin Genetics Inc., PP only
Search again
Enter part or all of the issuer name:
Market:
All markets
No structured products
Bank loans
Canadian bonds
CLOs
Convertibles
Distressed debt
Emerging markets
High yield
Investment grade
Liability management
Municipals
PIPEs
Preferreds
Private placements
All leveraged markets
Structured products
Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each.
All others are $1.00 each. Headlines in
gray
are not currently covered by your subscription.
Interleukin Genetics Inc.
8/1/2016
PP
Interleukin Genetics plans $5.59 million private placement of shares
5/13/2016
PP
Interleukin Genetics registers $15 million of stock for units offer
12/23/2014
PP
Interleukin Genetics settles $5.03 million private placement of stock
5/20/2013
PP
Interleukin Genetics completes $12 million private placement of stock
7/2/2012
PP
Interleukin Genetics wraps $3 million convertible preferreds placement
4/18/2012
PP
Interleukin draws $1.32 million on $14.32 million facility with Pyxis
3/5/2010
PP
Market Commentary:
General Moly seeks $80 million; Glen Rose seals convertible deal; YM Biosciences to sell units
3/5/2010
PP
New Issue: Interleukin heralds $5.25 million registered direct offering of units
8/21/2006
BTPP
New Issue: Interleukin Genetics closes $15.61 million private placement of stock
©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.
